右美托咪定与其他镇静药在重症监护室机械通气成人中的比较:随机试验的系统评价与Meta分析
该系统评价与Meta分析共纳入77项随机试验(n=11,997),比较右美托咪定与其他镇静药在ICU机械通气成人中的效果。结果显示,右美托咪定降低谵妄风险(RR 0.67,95%CI 0.55-0.81;中等确定性),缩短机械通气时间(MD -1.8小时,95%CI -2.89至-0.71;低确定性)和ICU住院时间(MD -0.32天,95%CI -0.42至-0.22;低确定性),但增加心动过缓(RR 2.39,95%CI 1.82-3.13;中等确定性)和低血压(RR 1.32,95%CI 1.07-1.63;低确定性)风险。
要点
- 与其它镇静药相比,右美托咪定降低ICU机械通气成人谵妄风险(RR 0.67,95%CI 0.55-0.81;中等确定性)。
- 右美托咪定轻度缩短机械通气时间(MD -1.8小时,95%CI -2.89至-0.71;低确定性)和ICU住院时间(MD -0.32天,95%CI -0.42至-0.22;低确定性)。
- 使用右美托咪定增加心动过缓风险(RR 2.39,95%CI 1.82-3.13;中等确定性)。
- 使用右美托咪定增加低血压风险(RR 1.32,95%CI 1.07-1.63;低确定性)。
适用人群与场景
- ICU内机械通气的成人患者。
研究设计与关键结果
- 研究类型:系统评价与Meta分析,纳入77项随机临床试验(n=11,997),比较右美托咪定与其他镇静药在ICU机械通气成人中的效果。
- 主要终点:与其它镇静药相比,右美托咪定降低谵妄风险(RR 0.67,95%CI 0.55至0.81;中等确定性)。
- 次要终点:右美托咪定缩短机械通气时间(MD -1.8小时,95%CI -2.89至-0.71;低确定性)和ICU住院时间(MD -0.32天,95%CI -0.42至-0.22;低确定性)。
- 不良事件:右美托咪定增加心动过缓风险(RR 2.39,95%CI 1.82至3.13;中等确定性)和低血压风险(RR 1.32,95%CI 1.07至1.63;低确定性)。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入77项随机临床试验(n=11,997),采用随机效应模型。
- 证据确定性:谵妄和心动过缓为中等确定性;机械通气时间、ICU住院时间和低血压为低确定性。
对床旁实践的改变
- 在ICU机械通气成人中,与其它镇静药相比,使用右美托咪定可降低谵妄风险,并轻度缩短机械通气时间和ICU住院时间,但需注意心动过缓和低血压风险增加。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Conventional gabaminergic sedatives such as benzodiazepines and propofol are commonly used in mechanically ventilated patients in the intensive care unit (ICU). Dexmedetomidine is an alternative sedative that may achieve lighter sedation, reduce delirium, and provide analgesia. Our objective was to perform a comprehensive systematic review summarizing the large body of evidence, determining if dexmedetomidine reduces delirium compared to conventional sedatives. We searched MEDLINE, EMBASE, CENTRAL, ClinicalTrials.gov and the WHO ICTRP from inception to October 2021. Independent pairs of reviewers identified randomized clinical trials comparing dexmedetomidine to other sedatives for mechanically ventilated adults in the ICU. We conducted meta-analyses using random-effects models. The results were reported as relative risks (RRs) for binary outcomes and mean differences (MDs) for continuous outcomes, with corresponding 95% confidence intervals (CIs). In total, 77 randomized trials (n = 11,997) were included. Compared to other sedatives, dexmedetomidine reduced the risk of delirium (RR 0.67, 95% CI 0.55 to 0.81; moderate certainty), the duration of mechanical ventilation (MD - 1.8 h, 95% CI - 2.89 to - 0.71; low certainty), and ICU length of stay (MD - 0.32 days, 95% CI - 0.42 to - 0.22; low certainty). Dexmedetomidine use increased the risk of bradycardia (RR 2.39, 95% CI 1.82 to 3.13; moderate certainty) and hypotension (RR 1.32, 95% CI 1.07 to 1.63; low certainty). In mechanically ventilated adults, the use of dexmedetomidine compared to other sedatives, resulted in a lower risk of delirium, and a modest reduction in duration of mechanical ventilation and ICU stay, but increased the risks of bradycardia and hypotension.
参考来源
- Lewis K, Alshamsi F, Carayannopoulos KL, et al. Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials. Intensive Care Med. 2022. PMID: 35648198. doi:10.1007/s00134-022-06712-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。